REAL-WORLD ADHERENCE TO SINGLE-INHALER VS MULTIPLE-INHALER TRIPLE THERAPY AMONG PATIENTS WITH COPD IN A COMMERCIALLY INSURED US POPULATION

被引：11
|
作者：
Bogart, Michael
Wu, Benjamin
Germain, Guillaume
Laliberte, Francois
MacKnight, Sean
Jung, Young
Duh, Mei
机构：
来源：
CHEST | 2020年 / 158卷 / 04期
关键词：
D O I：
10.1016/j.chest.2020.08.1548
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1773A / 1774A
页数：2
相关论文
共 50 条
  • [21] Economic impact of implementing prescription of single-inhaler triple therapies versus current multiple-inhaler triple therapies for COPD in the Apulia Region
    Resta, Emanuela
    Scioscia, Giulia
    Lacedonia, Donato
    Quarato, Carla Maria Irene
    Panza, Francesco
    Resta, Onofrio
    Lepore, Giorgia
    Buonamico, Enrico
    Di Lecce, Valentina
    Carpagnano, Giovanna Elisiana
    Barbaro, Maria Pia Foschino
    Rossi, Noemi
    BMC HEALTH SERVICES RESEARCH, 2022, 22 (01)
  • [22] Comparative adherence and persistence of single-inhaler and multiple-inhaler triple therapies among patients with chronic obstructive pulmonary disease in Japan: a retrospective cohort study
    Joksaite, Sandra
    Wood, Robert
    Ismaila, Afisi
    Camidge, Lucinda
    Mizukami, Akiko
    Czira, Alexandrosz
    Massey, Olivia
    Yarita, Masao
    Compton, Chris
    Siddiqui, Rad
    Jennison, Thomas
    Ishii, Takeo
    Hashimoto, Kenichi
    Rothnie, Kieran J.
    BMJ OPEN, 2024, 14 (12):
  • [23] A Real-World Analysis of Treatment Patterns and Clinical Characteristics Among Patients with COPD Who Initiated Multiple-Inhaler Triple Therapy in New Zealand
    Xu, Xiaomeng
    Milea, Dominique
    Rojas, Aldo Amador Navarro
    Braganza, Anthony
    Holbrook, Tim
    Marett, Brett
    Young, Robert
    Scott, Raewyn J.
    Gribben, Barry
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2021, 16 : 1835 - 1850
  • [24] Economic impact of implementing prescription of single-inhaler triple therapies versus current multiple-inhaler triple therapies for COPD in the Apulia Region
    Emanuela Resta
    Giulia Scioscia
    Donato Lacedonia
    Carla Maria Irene Quarato
    Francesco Panza
    Onofrio Resta
    Giorgia Lepore
    Enrico Buonamico
    Valentina Di Lecce
    Giovanna Elisiana Carpagnano
    Maria Pia Foschino Barbaro
    Noemi Rossi
    BMC Health Services Research, 22
  • [25] Real-world evidence with extrafine single-inhaler triple therapy in asthma: the TriMaximize study
    Gessner, C.
    Akyildiz, B.
    Cesarz, K.
    Sauer, A.
    Bogoevska, V
    Criee, P. C.
    PNEUMOLOGIE, 2022, 76 : S7 - S8
  • [26] Cost-effectiveness of single- vs multiple-inhaler triple therapy in a UK COPD population: INTREPID trial
    Kendall, Robyn
    Shukla, Soham
    Martin, Alan
    Shah, Dhvani
    Midwinter, Dawn
    Boucot, Isabelle
    Risebrough, Nancy A.
    Jones, Paul
    Compton, Chris
    Ismaila, Afisi
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [27] TRICOP - A real-world effectiveness study with a single-inhaler extrafine triple therapy over 52 weeks in Austrian patients with COPD
    Marth, Katharina
    Renner, Andreas
    Pohl, Wolfgang
    WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 (19-20) : 616 - 616
  • [28] TRICOP - A Real-world effectiveness study with a single-inhaler extrafine triple therapy over 52 weeks in Austrian patients with COPD
    Marth, Katharina
    Renner, Andreas
    Pohl, Wolfgang
    RESPIRATORY MEDICINE, 2021, 182
  • [29] Real-World Study of Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol on Asthma Control in the US
    Bogart, Michael
    Germain, Guillaume
    Laliberte, Francois
    Mahendran, Malena
    Duh, Mei Sheng
    Dirocco, Kristi
    Noorduyn, Stephen G.
    Paczkowski, Rosirene
    Balkissoon, Ronald
    JOURNAL OF ASTHMA AND ALLERGY, 2023, 16 : 1309 - 1322
  • [30] Single-Inhaler Triple versus Dual Therapy in Patients with COPD Reply
    Lipson, David A.
    Criner, Gerard J.
    Lomas, David A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (06): : 592 - 593
12345